MMSI Stock Falls Despite CE Mark Win for Embosphere in Knee OA Care
Merit Medical secures CE Mark for Embosphere, expanding its use in knee osteoarthritis treatment with a minimally invasive alternative.
Zacks·14h ago
More News
BDX vs. MMSI: Which Stock Should Value Investors Buy Now?
BDX vs. MMSI: Which Stock Is the Better Value Option?
Zacks·14h ago
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·5d ago
COO vs. MMSI: Which Stock Is the Better Value Option?
COO vs. MMSI: Which Stock Is the Better Value Option?
Zacks·21d ago
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·26d ago
Merit Medical (MMSI) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·1mo ago
Hologic Eyes Organic Growth Rebound in 2026 on Breast Health Strength
HOLX targets a mid-single-digit organic growth rebound in 2026, powered by Breast Health recovery and new product innovation.
Zacks·1mo ago
XRAY or MMSI: Which Is the Better Value Stock Right Now?
XRAY vs. MMSI: Which Stock Is the Better Value Option?
Zacks·1mo ago
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
MMSI beats second-quarter 2025 earnings estimates as gross margin expands and strong U.S. and Cardiovascular sales drive revenue growth.
Zacks·2mo ago
Merit Medical (MMSI) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.